Member Login
  1. Stocks
    2. /
  2. Knight Therapeutics Inc. (TSX: GUD)
    3. /

TSX:GUD (Knight Therapeutics Inc.)

About GUD

Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing innovative pharmaceutical products, consumer health products, and medical devices in Canada and select international markets. Knight finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Knight Therapeutics Inc. (TSX: GUD) Latest News

    Workers use a microscope to do medical research in a modern laboratory.
    Dividend Stocks

    2 Undervalued Canadian Stocks to Buy Now in May 2025

    | Amy Legate-Wolfe

    These undervalued Canadian stocks won't be down for long, especially for long-term investors.

    Read more »

    Doctor talking to a patient in the corridor of a hospital.
    Dividend Stocks

    Why I’d Consider These Top Healthcare Stocks for a $10,000 Long-Term Investment

    | Christopher Liew, CFA

    Three TSX stocks are suitable options for long-term investors seeking exposure to the healthcare sector.

    Read more »

    Stethoscope with dollar shaped cord
    Dividend Stocks

    Got $4,000? 4 Healthcare Stocks to Buy and Hold Forever

    | Amy Legate-Wolfe

    These healthcare stocks may not sound exciting, but the future growth opportunities certainly are.

    Read more »

    Nurse uses stethoscope to listen to a girl's heartbeat
    Tech Stocks

    3 Top Healthcare Sector Stocks for Canadian Investors in 2025

    | Aditya Raghunath

    Investing in TSX healthcare stocks such as Kneat.com can help Canadians generate outsized gains in 2025 and beyond.

    Read more »

    Workers use a microscope to do medical research in a modern laboratory.
    Dividend Stocks

    Got $4,000? 4 Healthcare Stocks to Buy and Hold Forever

    | Adam Othman

    Consider adding these four healthcare stocks to your portfolio if you have the capital to invest in the stock market…

    Read more »

    doctor uses telehealth
    Dividend Stocks

    Got $4,000? 4 Healthcare Stocks to Buy and Hold Forever

    | Amy Legate-Wolfe

    Healthcare stocks will always be a part of the market as essential investments, but these four look like strong long-term…

    Read more »

    Rocket lift off through the clouds
    Dividend Stocks

    3 TSX Stocks Ready to Explode in Value

    | Christopher Liew, CFA

    These stocks in rate-sensitive sectors could seriously break out after the rate cut.

    Read more »

    A doctor takes a patient's blood pressure in a clinical office.
    Dividend Stocks

    TSX Healthcare in April 2024: The Best Stocks to Buy Right Now

    | Christopher Liew, CFA

    TSX’s healthcare sector is not as popular as the heavyweight sectors, but it has three of the best stocks you…

    Read more »

    Stocks for Beginners

    2 Healthcare Stocks You Can Buy and Hold for the Next Decade

    | Amy Legate-Wolfe

    These two healthcare stocks are showing strong signs of growth for the next decade and are already improving by leaps…

    Read more »

    Dividend Stocks

    3 Growth Stocks to Invest $1,000 in Right Now

    | Christopher Liew, CFA

    Canadians can invest $1,000 in three growth stocks that are well-positioned to deliver far superior returns.

    Read more »

    Dividend Stocks

    2 Top Pharmaceutical Stocks to Buy on the TSX Today

    | Adam Othman

    Consider investing in these two TSX stocks if you want exposure to the pharmaceutical industry’s performance on the Canadian stock…

    Read more »

    Workers use a microscope to do medical research in a modern laboratory.
    Investing

    4 Biotech Stocks That Could Break Through the Market

    | Christopher Liew, CFA

    Four TSX biotech stocks could deliver outsized gains in 2023, as they are poised to break through the market soon.

    Read more »